查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413223

亞磷醯胺市場：按類型、最終用戶分類 - 全球預測 2024-2030

Phosphoramidite Market by Type (DNA Phosphoramidites, Dye-Labeled Phosphoramidites, RNA Phosphoramidites), End-User (Academic & Research Institutions, Contract Research Organizations, Pharmaceutical & Biotechnology) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年亞磷醯胺市場規模為12.8億美元，預計2024年將達13.8億美元，2030年將達到21.3億美元，複合年成長率為7.49%。

亞磷醯胺的全球市場

主要市場統計
基準年[2023] 12.8億美元
預測年份 [2024] 13.8億美元
預測年份 [2030] 21.3億美元
複合年成長率（%） 7.49%
亞磷醯胺市場-IMG1

亞磷醯胺是一類常用於固相寡核苷酸合成中合成核酸（例如 DNA 和 RNA）的化合物。亞磷醯胺是有機磷化合物，含有透過氮原子與胺基連接的磷原子和各種保護基團以控制反應性。隨著高通量序列測定技術的活性化，基因組學研究的興起以及研究大規模遺傳資訊的需求正在擴大亞磷醯胺的用途。人們對個人化醫療的日益關注正在推動對亞磷醯胺的需求，個人化醫療旨在根據個人的基因組成提供量身定做的醫療保健解決方案。與亞磷醯胺相關的高成本和可擴展性阻礙了市場成長。合成方法和亞磷醯胺技術的不斷進步為提高效率、產量和成本效益提供了機會。

區域洞察

特別是在美國和加拿大，成熟的製藥和生物技術產業正在推動對亞磷醯胺的需求，亞磷醯胺是合成核酸療法和研究工具的重要組成部分。包括美國FDA 在內的監管機構正在為基於核酸的療法的開發提供指導和支持，這正在推動亞磷醯胺在該地區的採用並推動市場成長。個人化醫療的努力正在不斷增加，旨在根據個人的遺傳資訊提供量身定做的醫療保健解決方案，預計將為歐洲、中東和非洲市場的亞磷醯胺製造商創造商機。亞太地區各國政府透過各種措施和資助計畫積極支持生物技術和生命科學領域的發展。例如，中國推出「中國製造2025」計劃，推動包括生物技術在內的先進製造業發展。政府的支持和資助正在促進研究和開發活動，並為亞磷醯胺製造商創造合作機會並為市場成長做出貢獻。

FPNV定位矩陣

FPNV定位矩陣對於評估亞磷醯胺市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對亞磷醯胺市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-亞磷醯胺市場的市場規模和預測是多少？

在 2-亞磷醯胺市場預測期間內，有哪些產品、細分市場、應用和領域值得考慮投資？

3-亞磷醯胺市場的技術趨勢和法律規範是什麼？

4-亞磷醯胺市場主要供應商的市場佔有率為何？

進入5-亞磷醯胺市場的合適型態和策略手段有哪些？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 基因研究、診斷、治療和生物技術領域對寡核苷酸的需求不斷增加
      • 隨著序列測定技術的出現，基因組學研究不斷取得進展
      • 製藥和生物技術產業的擴張
    • 抑制因素
      • 亞磷醯胺合成的高成本和可擴展性問題
    • 機會
      • 亞磷醯胺合成方法與技術不斷進步
      • 個人化醫療的進步帶來巨大潛力
    • 任務
      • 與亞磷醯胺合成相關的環境與安全問題
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章亞磷醯胺市場：依類型

  • DNA亞磷醯胺
  • 染料標記的亞磷醯胺
  • RNA亞磷醯胺
  • 特殊亞磷醯胺

第7章亞磷醯胺市場：依最終用戶分類

  • 學術/研究機構
  • 合約研究組織
  • 製藥和生物技術

第8章 南北美洲亞磷醯胺市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區亞磷醯胺市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲亞磷醯胺市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 合約、合作和夥伴關係

第12章競爭產品組合

  • 主要公司簡介
    • AAT Bioquest, Inc.
    • Actylis
    • Amadis Chemical Company Limited
    • American International Chemical, LLC
    • Bioneer Corporation
    • Biosynth Ltd.
    • BOCSCI Inc.
    • ChemGenes Corporation
    • Creative Biolabs
    • Hongene Biotech Corporation
    • Huaren Science and Technology Co., Ltd.
    • Integrated DNA Technologies, Inc. by Danaher Corporation
    • LGC Limited
    • Lumiprobe Corporation
    • Maravai LifeSciences
    • MedChemExpress
    • Merck KGaA
    • PolyOrg, Inc.
    • QIAGEN NV
    • SBS Genetech Co., Ltd.
    • STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd.
    • Thermo Fisher Scientific Inc.
    • Tokyo Chemical Industry Co., Ltd.
    • Twist Bioscience Corporation
  • 主要產品系列

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-EA74537D7BA3

[190 Pages Report] The Phosphoramidite Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.38 billion in 2024, at a CAGR 7.49% to reach USD 2.13 billion by 2030.

Global Phosphoramidite Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.28 billion
Estimated Year [2024] USD 1.38 billion
Forecast Year [2030] USD 2.13 billion
CAGR (%) 7.49%
Phosphoramidite Market - IMG1

Phosphoramidite is a class of compounds commonly used to synthesize nucleic acids, such as DNA and RNA, during solid-phase oligonucleotide synthesis. Phosphoramidites are organic phosphorus compounds that contain a phosphorus atom bonded to an amino group through a nitrogen atom and various protecting groups to control reactivity. Growing genomics research activities with the advent of high-throughput sequencing technologies and the need for studying genetic information on a large scale are expanding the usage of phosphoramidite. Increasing focus on personalized medicine that aims to provide tailored healthcare solutions based on an individual's genetic makeup elevates the demand for phosphoramidite. High cost and scalability associated with phosphoramidite hampers market growth. Continuous advancements in synthesis methods and phosphoramidite techniques present opportunities for improvement in efficiency, yield, and cost-effectiveness.

Regional Insights

The presence of well-established pharmaceutical and biotechnology industries, particularly in the United States and Canada, drives the demand for phosphoramidites as essential building blocks in synthesizing nucleic acid-based therapeutics and research tools. Regulatory agencies, including the FDA in the United States, provide guidelines and support for the development of nucleic acid-based therapeutics, which facilitates the adoption of phosphoramidites in the region and encourages market growth. Increasing personalized medicine initiatives, which aim to provide tailored healthcare solutions based on an individual's genetic information, is expected to create opportunities for phosphoramidite manufacturers in the EMEA market. Governments in the Asia-Pacific region actively support the development of their biotechnology and life sciences sectors through various initiatives and funding programs. For instance, China has launched the "Made in China 2025" initiative to promote the development of advanced manufacturing, including biotechnology. Government support and funding facilitate research and development activities, creating opportunities for phosphoramidite manufacturers to collaborate and contribute to the market's growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Phosphoramidite Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Phosphoramidite Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Phosphoramidite Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Actylis, Amadis Chemical Company Limited, American International Chemical, LLC, Bioneer Corporation, Biosynth Ltd., BOCSCI Inc., ChemGenes Corporation, Creative Biolabs, Hongene Biotech Corporation, Huaren Science and Technology Co., Ltd., Integrated DNA Technologies, Inc. by Danaher Corporation, LGC Limited, Lumiprobe Corporation, Maravai LifeSciences, MedChemExpress, Merck KGaA, PolyOrg, Inc., QIAGEN N.V., SBS Genetech Co., Ltd., STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd., Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co., Ltd., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Phosphoramidite Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • DNA Phosphoramidites
    • Dye-Labeled Phosphoramidites
    • RNA Phosphoramidites
    • Speciality Phosphoramidites
  • End-User
    • Academic & Research Institutions
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Phosphoramidite Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Phosphoramidite Market?

3. What are the technology trends and regulatory frameworks in the Phosphoramidite Market?

4. What is the market share of the leading vendors in the Phosphoramidite Market?

5. Which modes and strategic moves are suitable for entering the Phosphoramidite Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Phosphoramidite Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for oligonucleotides in genetic research, diagnostics, therapeutics, and biotechnology
      • 5.1.1.2. Continuous advancements in genomics research with the advent of sequencing technologies
      • 5.1.1.3. Expansion of the pharmaceutical and biotechnology industries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and scalability issues with phosphoramidite synthesis
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous advancements in synthesis methods and techniques for phosphoramidites
      • 5.1.3.2. High potential owing to rising advancements in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Environmental and safety concerns associated with phosphoramidite synthesis
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Phosphoramidite Market, by Type

  • 6.1. Introduction
  • 6.2. DNA Phosphoramidites
  • 6.3. Dye-Labeled Phosphoramidites
  • 6.4. RNA Phosphoramidites
  • 6.5. Speciality Phosphoramidites

7. Phosphoramidite Market, by End-User

  • 7.1. Introduction
  • 7.2. Academic & Research Institutions
  • 7.3. Contract Research Organizations
  • 7.4. Pharmaceutical & Biotechnology

8. Americas Phosphoramidite Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Phosphoramidite Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Phosphoramidite Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player
    • 11.3.1. Agreement, Collaboration, & Partnership
      • 11.3.1.1. Innovassynth and Actylis partner to address Nucleic Acid Supply Chain Vulnerabilities

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. AAT Bioquest, Inc.
    • 12.1.2. Actylis
    • 12.1.3. Amadis Chemical Company Limited
    • 12.1.4. American International Chemical, LLC
    • 12.1.5. Bioneer Corporation
    • 12.1.6. Biosynth Ltd.
    • 12.1.7. BOCSCI Inc.
    • 12.1.8. ChemGenes Corporation
    • 12.1.9. Creative Biolabs
    • 12.1.10. Hongene Biotech Corporation
    • 12.1.11. Huaren Science and Technology Co., Ltd.
    • 12.1.12. Integrated DNA Technologies, Inc. by Danaher Corporation
    • 12.1.13. LGC Limited
    • 12.1.14. Lumiprobe Corporation
    • 12.1.15. Maravai LifeSciences
    • 12.1.16. MedChemExpress
    • 12.1.17. Merck KGaA
    • 12.1.18. PolyOrg, Inc.
    • 12.1.19. QIAGEN N.V.
    • 12.1.20. SBS Genetech Co., Ltd.
    • 12.1.21. STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd.
    • 12.1.22. Thermo Fisher Scientific Inc.
    • 12.1.23. Tokyo Chemical Industry Co., Ltd.
    • 12.1.24. Twist Bioscience Corporation
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. PHOSPHORAMIDITE MARKET RESEARCH PROCESS
  • FIGURE 2. PHOSPHORAMIDITE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PHOSPHORAMIDITE MARKET DYNAMICS
  • FIGURE 7. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. PHOSPHORAMIDITE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. PHOSPHORAMIDITE MARKET SIZE, BY DNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PHOSPHORAMIDITE MARKET SIZE, BY DYE-LABELED PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PHOSPHORAMIDITE MARKET SIZE, BY RNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PHOSPHORAMIDITE MARKET SIZE, BY SPECIALITY PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. PHOSPHORAMIDITE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PHOSPHORAMIDITE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 101. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. PHOSPHORAMIDITE MARKET LICENSE & PRICING